Skip Ribbon Commands
Skip to main content

About The Workshop

Notice of Termination and Rescheduling

​The American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO), after careful consideration and comprehensive evaluation of currently available information related to the novel coronavirus (COVID-19) outbreak, have made the difficult decision to terminate the AACR/ASCO Methods in Clinical Cancer Research Workshop, originally scheduled for July 25-31, 2020, in Vail, Colorado.

We recognize that this unique program which offers a mix of education, training, and mentorship is highly valued by the cancer research community. Although the 2020 Workshop will not take place, we will be extending the eligibility by one (1) year in order to allow anyone who was eligible for the 2020 Workshop to apply again for the 2021 Workshop.

AACR and ASCO appreciate your patience and understanding during this unfortunate situation. If you have any questions, please email

Our heartfelt sympathies go out to everyone impacted by this global health crisis.

ASCO Methods in Clinical Cancer Research Workshop

An intensive workshop in the essentials of effective clinical trial designs of therapeutic interventions in the treatment of cancer for clinical fellow and junior faculty clinical researchers in all oncology subspecialties, including radiation and surgical oncology and radiology.

Workshop Codirectors:
Thomas Braun, PhD

Manuel Hidalgo, MD, PhD
Julie M. Vose, MD

For those protocols using agents from a pharmaceutical company that are not FDA-approved for the disease under study, a letter of commitment from the collaborating company stating that drug will be supplied for the proposed trial or a copy of the correspondence with the company suggesting their likely support of the trial IS STRONGLY ENCOURAGED. Priority will be given to applicants that have a clear letter of support that is uploaded with the application (preferably a letter of commitment, but at minimum, a letter of intent).


Questions?: Please contact Kathryn Leonard, PhD, Scientific Program Administrator, Scientific Programs at

This activity has been approved for AMA PRA Category 1 Credits™.

This workshop is supported by an educational grant from the American Society for Radiation Oncology



Supported by the National Cancer Institute of the National Institutes of Health under Award Number R25CA068647. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.


Comments from Past Workshop Participants:

"Amazing experience - the most educational and inspiring experience of my residency. Inspiring and brilliant community. Wonderful, kind PDG leaders that guided us throughout the process and helped optimize our study design. The gold standard course for learning about clinical trial design."

"This was the best training experience I ever had. Fantastic mentors and colleagues. I didn't think it was possible to learn so much in less than a week! Thank you all so much!!"

"This was a wonderful opportunity. I never imagine I could get this much done in a week - write a full protocol, get feedback to improve my design and write it again, meet this many people and enjoy the scenery and zip lining at Vail! What I learned here will stay with me for life."

"The conference was spectacular!! I learned a tremendous amount about clinical trial design, and I'm confident that I now have the foundation needed to move forward in my career."

"This is THE best workshop or conference among all that I have ever attended throughout my entire career. Faculties were truly motivating and open to any questions or feedback. Having an opportunity to talk to mentors and other faculties during the office hour or small group sessions changed my view of career development."

"This was one of the best experiences of my entire residency training and I would recommend this course to any young faculty member or trainee."